Market Tracker

05/23 12:52pm ET
12.07
BATS BZX Real-Time Price
As of 12:52pm ET
 -0.01 / -0.08%
Today’s Change
8.67
Today|||52-Week Range
14.55
+12.80%
Year-to-Date
No recent news for Innoviva Inc.

Today’s Trading

Previous close12.08
Today’s open12.00
Day’s range12.00 - 12.16
Volume36,735
Average volume (3 months)1,268,217
Market cap$1.3B
Dividend yield--
Data as of 12:52pm ET, 05/23/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+111.32%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+117.48%
P/E ratio18.8
Price/Sales8.95
Price/Book--

Competitors

 Today’s
change
Today’s
% change
CORTCorcept Therapeutics...0.000.00%
EBSEmergent BioSolution...-0.16-0.54%
GBTGlobal Blood Therape...-0.70-2.33%
RGENRepligen Corp-0.54-1.38%
Data as of 12:51pm ET, 05/23/2017

Financials

Next reporting dateAugust 2, 2017
EPS forecast (this quarter)$0.28
Annual revenue (last year)$147.4M
Annual profit (last year)$59.5M
Net profit margin40.39%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts